Therapeutics News

The FDA notified Cambium Medical Technologies that its phase 1 study of topical fibrinogen-depleted human platelet lysate for treatment of dry eye disease can proceed, according to a company press release.

The American Optometric Association has demanded a retraction and apology from Fox News anchor Martha MacCallum for a comment she made on-air about optometrists prescribing painkillers and contributing to the opioid crisis.

CHICAGO – A phase 2 study showed SHP640 to have significantly better outcomes in clinical resolution and adenoviral eradication compared with vehicle in patients with acute adenoviral conjunctivitis, Abhijit Narvekar, MBBS, DPM, MS, reported here at the American Academy of Optometry meeting.

LAS VEGAS – The TrueTear from Allergan is now available by prescription for patients to use throughout the day as a way to create natural tears with neurostimulation.

OPUS-3 showed significantly improved symptoms of eye dryness with lifitegrast, as measured by eye dryness score, versus placebo in those with dry eye disease.

Human retinal pigment epithelial cells support replication of Ebola virus and release the virus in high titer, according to researchers who studied live Ebola virus and the ARPE-19 human ocular pigment epithelial cell line.

I have a message for the FDA: What surgeons really need in practicing medicine in the U.S. are approved products for unusual cases.

Researchers recommend that patients with chronic conditions requiring multiple, different eye drops wait 5 minutes between administration, according to a study in Optometry and Vision Science.

I recently saw an interesting patient at the request of her primary care physician. Earlier in the week she presented to her physician with a sore, swollen right lower eyelid. The doctor confirmed her suspicion for an internal stye and prescribed hot compresses and an antibiotic ointment.

Ocular herpes infections are presenting more often in the optometric practice, and experienced clinicians advocate for early detection and aggressive management.